![](/img/cover-not-exists.png)
A Phase I Study of Single-Agent Nilotinib or in Combination with Imatinib in Patients with Imatinib-Resistant Gastrointestinal Stromal Tumors
Demetri, G. D., Casali, P. G., Blay, J.-Y., von Mehren, M., Morgan, J. A., Bertulli, R., Ray-Coquard, I., Cassier, P., Davey, M., Borghaei, H., Pink, D., Debiec-Rychter, M., Cheung, W., Bailey, S. M.,Volume:
15
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-09-0542
Date:
September, 2009
File:
PDF, 147 KB
english, 2009